je.st
news
Tag: european
Germanys DB signs MoU with European Rail Industry to advance IRIS standard
2015-08-25 01:00:00| Railway Technology
German railway firm Deutsche Bahn (DB) and the European Railway Industry Association (Unife) have signed a memorandum of understanding (MoU) to advance the International Railway Industry Standard (IRIS).
Tags: standard
industry
advance
european
European rail services on high alert after foiled attack on French high-speed train
2015-08-24 14:34:00| Railway Technology
Major European rail services have bolstered security measures after the foiled attack on a Thalys service high-speed train on Friday.
Tags: services
high
french
alert
European Auto Sales Remain Strong, While Chinese Auto Sales Continue to Sink
2015-08-21 21:13:52| Auto Dealers - Topix.net
As we posted earlier this year , car sales in the European auto industry have been on the upswing for nearly two years. This continued in July as sales rose in Germany, France, Italy, and Spain .
Tags: auto
sales
continue
strong
MACOM To Showcase Fourth Generation GaN Technology For RF Energy Applications At Booth #235 At European Microwave Week (EuMW) 2015 In Paris, France
2015-08-21 09:07:30| rfglobalnet News Articles
M/A-COM Technology Solutions Holdings, Inc. (“MACOM”), a leading supplier of high-performance analog RF, microwave, millimeterwave and photonic semiconductor products, will showcase the industry’s broadest and most advanced Gallium Nitride (GaN) RF product and technology portfolio at European Microwave Week, September 6-11 in Paris, France at Booth #235. This Smart News Release features multimedia.
Tags: in
france
technology
week
New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA (sitagliptin) Will Be Presented at the European Society of Cardiology Congress
2015-08-20 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Additional Real-World Analyses from DYSIS and DYSIS II Assessing the Treatment of Dyslipidemia to be Presented KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that new analyses from the investigational IMPROVE-IT (IMProved Reduction of Outcomes: VYTORIN Efficacy International Trial) study of VYTORIN (ezetimibe and simvastatin), the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial of JANUVIA (sitagliptin), and real-world data from the Dyslipidemia International Study (DYSIS I and DYSIS II) will be presented at the upcoming European Socie Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orKim Hamilton, 908-391-0131orInvestor:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] next »